全文获取类型
收费全文 | 482篇 |
免费 | 80篇 |
出版年
2022年 | 4篇 |
2021年 | 5篇 |
2020年 | 8篇 |
2019年 | 8篇 |
2018年 | 15篇 |
2017年 | 8篇 |
2016年 | 10篇 |
2015年 | 13篇 |
2014年 | 20篇 |
2013年 | 21篇 |
2012年 | 28篇 |
2011年 | 27篇 |
2010年 | 14篇 |
2009年 | 11篇 |
2008年 | 17篇 |
2007年 | 20篇 |
2006年 | 15篇 |
2005年 | 23篇 |
2004年 | 8篇 |
2003年 | 14篇 |
2002年 | 18篇 |
2001年 | 9篇 |
2000年 | 8篇 |
1999年 | 12篇 |
1998年 | 5篇 |
1995年 | 6篇 |
1993年 | 4篇 |
1992年 | 10篇 |
1991年 | 12篇 |
1990年 | 6篇 |
1989年 | 9篇 |
1988年 | 9篇 |
1987年 | 11篇 |
1986年 | 12篇 |
1985年 | 9篇 |
1984年 | 8篇 |
1983年 | 8篇 |
1982年 | 9篇 |
1981年 | 5篇 |
1978年 | 4篇 |
1977年 | 6篇 |
1976年 | 4篇 |
1975年 | 17篇 |
1974年 | 18篇 |
1973年 | 11篇 |
1972年 | 9篇 |
1971年 | 3篇 |
1970年 | 3篇 |
1969年 | 5篇 |
1967年 | 3篇 |
排序方式: 共有562条查询结果,搜索用时 15 毫秒
31.
32.
Yoshikazu Furusawa Shinji Yamada Shunsuke Itai Takuro Nakamura Miyuki Yanaka Masato Sano Hiroyuki Harada Masato Fukui Mika K. Kaneko Yukinari Kato 《Biochemistry and Biophysics Reports》2019
Monoclonal antibodies (mAbs) against human, mouse, rat, rabbit, dog, cat, and bovine podoplanin (PDPN), a lymphatic endothelial cell marker, have been established in our previous studies. However, mAbs against horse PDPN (horPDPN), which are useful for immunohistochemical analysis, remain to be developed. In the present study, mice were immunized with horPDPN-overexpressing Chinese hamster ovary (CHO)-K1 cells (CHO/horPDPN), and hybridomas producing mAbs against horPDPN were screened using flow cytometry. One of the mAbs, PMab-219 (IgG2a, kappa), specifically detected CHO/horPDPN cells via flow cytometry and recognized horPDPN protein using Western blotting. Furthermore, PMab-219 strongly stained CHO/horPDPN via immunohistochemistry. These findings suggest that PMab-219 is useful for investigating the function of horPDPN. 相似文献
33.
Yukinari Kato Yoshikazu Furusawa Shinji Yamada Shunsuke Itai Junko Takei Masato Sano Mika K. Kaneko 《Biochemistry and Biophysics Reports》2019
Podoplanin (PDPN) is known as a lymphatic endothelial cell marker. Monoclonal antibodies (mAbs) against human, mouse, rat, rabbit, dog, cat, bovine, pig, and horse PDPN have been established in our previous studies. However, mAbs against alpaca PDPN (aPDPN), required for immunohistochemical analysis, remain to be developed. In the present study, we employed the Cell-Based Immunization and Screening (CBIS) method for producing anti-aPDPN mAbs. We immunized mice with aPDPN-overexpressing Chinese hamster ovary (CHO)-K1 cells (CHO/aPDPN), and hybridomas producing mAbs against aPDPN were screened using flow cytometry. One of the mAbs, PMab-225 (IgG2b, kappa), specifically detected CHO/aPDPN cells via flow cytometry and recognized the aPDPN protein on Western blotting. Further, PMab-225 strongly stained lung type I alveolar cells, colon lymphatic endothelial cells, and kidney podocytes via immunohistochemistry. These findings demonstrate that PMab-225 antibody is useful to investigate the function of aPDPN via different techniques. 相似文献
34.
Yoshikazu Furusawa Shinji Yamada Shunsuke Itai Takuro Nakamura Junko Takei Masato Sano Hiroyuki Harada Masato Fukui Mika K. Kaneko Yukinari Kato 《Biochemistry and Biophysics Reports》2019
Monoclonal antibodies (mAbs) against not only human, mouse, and rat but also rabbit, dog, cat, bovine, pig, and horse podoplanins (PDPNs) have been established in our previous studies. PDPN is used as a lymphatic endothelial cell marker in pathological diagnoses. However, mAbs against Tasmanian devil PDPN (tasPDPN), which are useful for immunohistochemical analysis, remain to be developed. Herein, mice were immunized with tasPDPN-overexpressing Chinese hamster ovary (CHO)-K1 (CHO/tasPDPN) cells, and hybridomas producing mAbs against tasPDPN were screened using flow cytometry. One of the mAbs, PMab-233 (IgG1, kappa), specifically detected CHO/tasPDPN cells by flow cytometry and recognized tasPDPN protein by western blotting. Furthermore, PMab-233 strongly detected CHO/tasPDPN cells by immunohistochemistry. These findings suggest that PMab-233 may be useful as a lymphatic endothelial cell marker of the Tasmanian devil. 相似文献
35.
36.
37.
38.
Recent introduction of the intravenous anesthetic propofol as an ICU sedative has allowed a deeply sedated state to be maintained for extended periods in the ICU without delays in emergence. Although such sedation has been advocated to promote physiologic sleep, little evidence exists to support such a strategy. To explore propofol's effect on sleep regulation, we administered propofol directly into the medial preoptic area (MPA) of the rat, an anatomic site where administration of other sedatives (triazolam and phenobarbital) also induce sleep. We performed three two-hour sleep studies in the daytime with the lights on following the administration of propofol (8 ng or 40 ng) or vehicle (intralipid). The higher dose of propofol significantly reduced sleep latency and increased nonREM and total sleep times when compared to vehicle. REM sleep times, intermittent waking times and number of transitions were not altered. Mean nonREM sleep bout length was increased significantly at the higher dose. These findings suggest that propofol may enhance sleep by acting at a hypothalamic site. 相似文献
39.
40.
Mendelson WB 《Life sciences》1999,65(25):PL301-PL307
In view of interest in the ventrolateral preoptic area (VLPO), based on FOS protein accumulation during sleep as well as its output pathways to areas involved in sleep regulation, we have examined the effects of microinjections of triazolam into the VLPO. It was found that two doses of triazolam, noted previously to enhance sleep when injected into the medial preoptic area, had no significant effect on sleep or core temperature when administered into the VLPO. Although these data do not bear on the possibility that the VLPO is involved in physiological sleep regulation, they suggest that it is not a site of the pharmacologic action of hypnotic benzodiazepines. 相似文献